Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Revolutionary Cancer Treatment Shows 82% Success Rate

A groundbreaking new treatment called TAR-200 has achieved remarkable results in fighting bladder cancer, eliminating tumors in 82% of patients whose cancer had previously resisted all other therapies. The innovative device looks like a miniature pretzel and contains the chemotherapy drug gemcitabine, which is inserted into the bladder through a catheter and slowly releases medication for three weeks per treatment cycle. This revolutionary approach proved dramatically more effective than traditional treatments, with most patients seeing their cancer disappear after just three months, and nearly half remaining cancer-free a full year later.

What makes this breakthrough so significant is that it offers hope to patients who had exhausted all other treatment options and were facing bladder removal surgery as their only remaining choice. The slow-release system allows the chemotherapy to penetrate deeper into bladder tissue over weeks rather than hours, making it far more effective at destroying cancer cells while maintaining minimal side effects. Dr. Sia Daneshmand, who led the clinical trial at 144 locations worldwide, called it “the most effective therapy reported to date for the most common form of bladder cancer.” The FDA has granted TAR-200 priority review status, meaning this life-changing treatment could be available to patients sooner than typical drug approvals, offering new hope to thousands of people fighting this challenging disease.

PrevPreviousThe Protein Discovery That Could Change Everything About Memory Loss
NextThe Texas Reunion That Was 56 Years in the MakingNext

Recent Articles

Happy News

For The First Time In History Medicare Is Covering Weight Loss Drugs And The Price Is $50 A Month

May 14, 2026

Starting July 1, 2026 eligible Medicare enrollees will be able to access GLP-1 weight loss medications including Wegovy, Zepbound, and the newer drug Foundayo for a flat $50 monthly copay, in a historic first for the program, which has never before covered anti-obesity medications despite covering many of the serious

Read More
Happy News

Swedish Scientists Just Grew The Cells Type 1 Diabetes Destroys From Scratch

May 13, 2026

Scientists at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed a more reliable method for growing insulin-producing cells from human stem cells, and the results published in Stem Cell Reports represent one of the most encouraging steps yet toward a potential treatment for type 1 diabetes.

Read More
Happy News

New Research Reveals The Personality Trait That Predicts Whether You Will Seek Out A Cat When Stressed

May 12, 2026

A study published in the journal Anthrozoös, conducted by researchers at Washington State University and KU Leuven in Belgium, has identified the personality trait most likely to predict whether someone will seek out a cat for stress relief rather than a dog, and the answer has a name: emotionality. Researchers

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.